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Tissue macrophages play an important role in all stages of pregnancy, including uterine stro-
mal remodeling (decidualization) before embryo implantation, parturition, and post-partum
uterine involution. The activation state and function of utero-placental macrophages are
largely dependent on the local tissue microenvironment. Thus, macrophages are involved
in a variety of activities such as regulation of immune cell activities, placental cell invasion,
angiogenesis, and tissue remodeling. Disruption of the uterine microenvironment, particu-
larly during the early stages of pregnancy (decidualization, implantation, and placentation)
can have profound effects on macrophage activity and subsequently impact pregnancy
outcome. In this review, we will provide an overview of the temporal and spatial regulation
of utero-placental macrophage activation during normal pregnancy in human beings and
rodents with a focus on more recent findings. We will also discuss the role of M1/M2
dysregulation within the intrauterine environment during adverse pregnancy outcomes.
Keywords: macrophages, M1/M2, normal pregnancy, complicated pregnancy, uterine atherosis, spiral artery,
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INTRODUCTION
Macrophages within the maternal–fetal compartment have been
a research focus for over 30 years. Both maternal and fetal derived
macrophages play an important role in all stages of pregnancy.
These cells support a variety of processes essential for successful
pregnancy such as remodeling of the uterine connective tissues and
blood vessels, regulation of trophoblast (fetal cell) implantation,
immune-tolerance toward fetal antigens, immunomodulation of
neighboring leukocytes, and initiation of parturition (1–5). All of
these functions are manifestations of macrophage polarity or state
of activation, which at the most basic level has been referred to
as M1 and M2. M1 macrophages display the capacity to present
antigen, produce IL-12, IL-23, reactive oxygen species (6, 7), and
skew T cell responses toward a TH1 or cell mediated immune
response (8). In contrast, M2 macrophages participate in tissue
remodeling, have immunosuppressive qualities, and promote TH2
or antibody mediated immune responses (6). In essence, M1/M2
activities arise from arginine metabolism via two enzymatic path-
ways (iNOS and arginase) that down regulate each other (7, 9).
The factors that influence which pathway dominates are based on
the surrounding signals that the macrophage receives as well as the
available arginine pool (7, 10). Thus, macrophage function, which
is a manifestation of the cell’s polarization or activation state, is
ultimately decided by the surrounding milieu.
The maternal–fetal interface is a unique environment in that
it comprises three distinct compartments: the placenta (fetal
origin), and maternal origin (endometrium or decidua, and
myometrium), which are infiltrated with fetal cells. Furthermore,
these compartments undergo dramatic changes in architecture
and leukocyte composition as gestation progresses. These changes
are necessary for placental development and tolerance of foreign
fetal antigens. Macrophages are present in all compartments
and during all stages of pregnancy (implantation, placentation,
fetal growth, and parturition) (11). Successful pregnancy requires
that the macrophage activation state remain regulated through-
out pregnancy. Indeed, inappropriate macrophage polarization
within the maternal–fetal compartments is associated with spon-
taneous abortion or miscarriage (12), inadequate remodeling of
the uterine vessels during placentation (12–14), and intrauterine
parasitic infections (15). In this review, we provide an overview
of M1/M2 dynamics relevant to the maternal–fetal interface,
the temporal and spatial changes in macrophage M1/M2 within
the maternal and fetal compartments during normal pregnancy,
and imbalanced M1/M2 dynamics associated with complicated
pregnancies.
M1 AND THE MANY SHADES OF M2
Macrophages display divergent phenotypes that were originally
described as M1or M2 polarity (7). M1 refers to the classically
activated macrophage whereby the cell displays the capacity to
present antigen, produce IL-12, IL-23, and reactive oxygen species
(6, 7). M1 polarized macrophages are more effective at antimi-
crobial killing and skewing T cell responses toward a TH1 or cell
mediated immune response (8). External stimuli known to pro-
mote M1 polarization include toll-like receptor (TLR4) agonists
such lipopolysaccharide (LPS) from E. coli, IFN-γ, TNF-α, and
GM-CSF (7, 16). In contrast, M2 polarized cells (alternatively acti-
vated cells) display abundant expression of mannose and scavenger
receptors and produce IL-10 and TGF-β (6). M2 macrophages par-
ticipate in tissue remodeling, have immunosuppressive qualities,
and promote TH2 or antibody mediated immune responses (6).
Stimuli that induce M2 polarization include IL-4, IL-10, IL-13,
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IL-33, TGF-β, and G-CSF (7, 16–19). Because of the broad range of
activities carried out by M2 macrophages, Mantovani et al. (6) later
proposed that these cells be further divided into M2a (induced by
IL-4 and IL-13), M2b (macrophages exposed to immune com-
plexes or toll-like receptor agonists), and M2c (induced by IL-10
and glucocorticoid hormones). These subcategories were based
on both the type of agonists responsible for triggering their dif-
ferentiation and the distinct functional profile induced by these
agonists. For example, M2a cells display the alternatively activated
phenotype typically attributed to M2 cells. M2b confers a Type
II phenotype, because it promotes TH2 responses and produces
both pro- and anti-inflammatory cytokines (TNF-α, IL-1, IL-6,
IL-10high, and IL-12low) (6). M2c confers an M2 macrophage that
produces IL-10, TGF-β, and extracellular matrix components (6).
At the most fundamental level, M1/M2 polarity is driven by
arginine metabolism and available arginine within the extracellu-
lar milieu. In essence, M1 is a product of iNOS pathway, which
drives the conversion of arginine to citrulline and NO, whereas
M2 is a product of the arginase pathway in which arginine is
hydrolyzed into ornithine and urea (7, 20). iNOS and arginase
pathways are antagonistic, not only do they compete for arginine
but also arginase directly inhibits NO synthase 2 (NOS2) (10).
Although M2 is defined by the arginase pathway (7, 9), in Man-
tovani et al.’s designation, M2b develops independent of arginase
activity, while M2a and M2c still require arginase activity (6).
A distinctive feature of the iNOS pathway is that its activation
requires extracellular arginine, even if an adequate level of intracel-
lular arginine is already present (21). Without sufficient arginine
iNOS is blocked at the translational level and NO is not produced
even in the presence of IFN-γ or LPS. Under these conditions, the
macrophage does not acquire an M1 phenotype, but still produces
TNF-α in response to IFN-γ or LPS (21). This condition bears
a resemblance to M2b macrophages (6). This dependency upon
extracellular arginine reserves may be particularly important dur-
ing pregnancy since placental tissues are rich in arginase I and
II (22), and therefore, placental extracellular arginine levels may
actually be too low for induction of M1 macrophages.
Several studies have attempted to characterize the func-
tional state of macrophages at the maternal–fetal interface dur-
ing different stages of a healthy pregnancy (Table 1). These
include transcriptome analysis (23, 24), methylation profil-
ing (25), characterization of cell surface markers (26–28), and











costaining for CD14 decidual
and placental macrophages
(Mφ) and mannose receptor
(M2 biomarker)
Confirmed that decidual and placental Mφ express mannose receptor
in vivo
(29)
CD14+ decidual Mφ surround endometrial glands in early pregnancy





Flow cytometry of decidual
Mφ
Decidual Mφ from early/mid gestation have higher CD80, CD86, and
HLA-DR expression than term Mφ
(26)
Mφ in decidua basalis express CD105, DC-SIGN, and mannose receptor
Gustafsson 2008 7–11 RNA Microarray analysis of
CD14+ Mφ isolated from
decidua and peripheral blood
The majority of genes upregulated in decidual Mφ were functionally
related to immunomodulation and tissue remodeling consistent with an
activated M2 phenotype
(23)
Houser 2011 6–12 Flow cytometry and RNA




Identified 2 decidual Mφ subsets: CD11cHI and CD11cLO (24)
CD11cLO decidual Mφ express genes associated with extracellular
matrix formation, muscle regulation, and tissue growth
CD11cHI decidual Mφ express genes associated with lipid metabolism
and inflammation
Svensson 2011 7–12 Phenotypic characterization
of decidual Mφ by flow
cytometry
RNA microarray on in vitro
differentiated Mφ cultures
Identified 2 decidual Mφ subsets: ICAM-3HI and ICAM-3LO
ICAM-3 expression on decidual Mφ positively correlated with CD11c
expression as reported by Houser and colleagues
M-CSF/IL-10 in vitro differentiated Mφ and decidual Mφ showed similar
cytokine secretion patterns (↑IL-10, IL-6, TNF, and CCL4)
(27)
Kim 2012 Term Methylome analysis of
decidual Mφ, Hofbauer
cells, neonatal, and maternal
blood monocytes (Mo)
Both decidual Mφ and Hofbauer cells exhibited hypermethylation of
genes encoding classical Mφ activation
(25)
Both decidual Mφ and Hofbauer cells exhibited hypomethylation of
genes encoding alternative Mφ macrophage activation
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immunohistochemistry (29). When viewed in the context of
M1 and M2, the results from these studies suggest that M2
macrophages or M2 subgroups are the predominant phenotype
in the decidua with a smaller subset of macrophages bearing some
characteristics of M1 or M2b (24). One drawback is that most of
these studies analyzed macrophages out of their in situ context so
the local factors responsible for triggering the differentiation of
these macrophage subsets are still unknown.
The role of phosphatidylserine receptor Tim-3 in macrophages
from the maternal–fetal interface has gained recent attention (30).
Tim-3 is recognized as a regulator of pro- and anti-inflammatory
innate immune responses (31), and Tim-3 expression is enhanced
in M2 immunoregulatory macrophages (32, 33). Therefore, Tim-3
may play an important role in maintaining macrophage medi-
ated immune tolerance at the maternal–fetal interface (31).
Indeed, Tim-3 facilitates phagocytic activity of apoptotic bodies
at the maternal–fetal interface, and blockade of Tim-3 on uterine
macrophages led to increased production of IFN-γ and TNF-α by
inflammatory granulocytes with subsequent rejection of the fetus
(30). To date, it is unknown if loss of Tim-3 or dysregulation of
Tim-3 occurs in adverse pregnancy outcome.
Hofbauer cells are macrophages that reside within the mes-
enchymal stroma of the chorionic villi (34), which are thought
to originate from fetal hematopoietic cells (35). In human pla-
centa, Hofbauer cells have been detected by 4 weeks gestation, and
their numbers increase during the first trimester and then decline
by term (36). Based on their hypermethylation patterns, Hofbauer
cells display a commitment to M2 in healthy pregnancy (25). Other
phenotypic features that suggest these cells are pro-M2 include
constitutive expression of DC-sign (CD209), high levels of CD163,
CD68, CD45, hyaluronan receptor LYVE-1, and HLA antigens A,
B, and C, IL-10, and TGF-β (37–39). Hofbauer cells may have a role
in placental angiogenesis, remodeling of the extracellular matrix,
and modulation of inflammation, which are M2 characteristics
(39–41). Although not a particular feature of macrophage func-
tion, it has been suggested that Hofbauer cells participate in the
regulation of stromal fluid balance, ion exchange, and transfer of
serum proteins to the vascular system (36).
ANATOMY OF THE MATERNAL–FETAL INTERFACE IN
RELATION TO MACROPHAGES
The various compartments of the maternal–fetal interface (pla-
centa, decidua, and myometrium) are anatomically distinguished
by the composition of the connective tissue and the leukocyte pop-
ulations present in each compartment. For example, macrophages
residing in the myometrium may be receiving signals from T-cells,
dendritic cells, and myocytes, whereas macrophages within the
decidua receive signals from decidualized stromal cells, uterine NK
cells, T-cells, and trophoblasts. In addition, decidual macrophages
respond to immunoregulatory compounds such as HLA-G, TGF-
β, and vasoactive intestinal peptide (VIP) that are produced by
adjacent trophoblasts (40–42).
The mammalian uterus has two distinct tissue layers: the
endometrium and myometrium. Macrophages are found inter-
spersed in both layers of the uterus. The luminal surface of
the endometrium consists of simple cuboidal epithelium that is
supported by underlying connective tissue. The endometrium
contains a complex vascular supply and a diverse population of
leukocytes that changes with stage of the menstrual cycle and stage
of pregnancy (43). The myometrium is composed of interlacing
bundles of smooth muscle. In human beings, the myometrium
exhibits minimal change during pregnancy (44). In rodents, how-
ever, the myometrium below the site of placental attachment
expands and develops into the metrial triangle (44). Prior to
embryo implantation, the endometrium begins to undergo struc-
tural changes referred to as decidualization, which is initiated by
increased progesterone levels (44, 45). The process of decidualiza-
tion in human beings stabilizes by 12 weeks gestation (46). The
physical changes that occur during decidualization include pro-
liferation of luminal epithelium, development of secretory glan-
dules with large apical protrusions (pinopodes) and microvilli,
and transformation of fibroblast-like endometrial stromal cells
into larger rounded cells (47, 48). In addition, endometrial cells
produce a variety of compounds that attract leukocytes to the
decidualized tissue such as prolactin, colony stimulating factor
1 (CSF-1), macrophage inhibitory factor (MIF), IL-15, insulin
growth factor binding protein-1 (IGFBP-1), and cyclooxygenase-2
(COX-2), and cell adhesion molecules (ICAM-1, VACM-1, LFA-
3, H-CAM) (41, 45, 48, 49). Both CSF-1and MIF influence the
recruitment of macrophages into the decidua (11, 43, 50, 51).
Following embryo implantation, the decidua differentiates into
two distinct regions: the decidua basalis, which refers to the por-
tion of the uterus attached to the placenta, and decidua parietalis,
which refers to the rest of the endometrium lining the main cavity
of the pregnant uterus. In human beings, macrophages within the
decidua basalis coexist with trophoblasts, CD56bright/CD16low NK
cells, and T-cells, 25% of which are CD4+/CD25+/FOXP3+ regu-
latory T-cells (Tregs) (11, 44). Within the decidua basalis, CD14+
macrophages and NK cells are often observed in aggregates in
association with spiral arteries (11, 52). Decidual macrophages are
also observed in close association with trophoblasts (40). Factors
released by neighboring trophoblasts may induce decidual tro-
phoblasts to display cell surface expression of CD14 and CD16,
exhibit increased phagocytic capacity, and secrete more IL-1β,
IL-10, and IP-10 (53).
The microenvironment within the myometrium slightly dif-
fers from the decidual basalis in that macrophages and T-cells
are the predominant leukocyte populations, and there are few
CD56bright/CD16low NK cells (54). In rats and mice, macrophages
are more predominant in the myometrium than in the decidua,
which has been attributed to higher CSF-1 concentrations within
this compartment (55). Trophoblasts are also present within the
inner third of the myometrium in both human beings and rats, but
not in mice (14, 56). Macrophages recruited into the myometrium
are important for the normal induction of labor and post-partum
uterine remodeling (5, 57).
Placentation in human beings, non-human primates, and
rodents is described as hemochorial because there are no barriers
between trophoblast cells and maternal blood (58). Hemocho-
rial placentation requires extensive tissue remodeling in which
the endometrium that becomes the decidua basalis is obliterated
and the uterine arteries are transformed from high resistance,
low-flow arteries to low resistance, and high-flow vessels (14). Dur-
ing remodeling of spiral arteries, the endothelium and smooth
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muscle cells are replaced by invading extravillous trophoblasts
and fibrinoid deposits (59). This complex process depends on
a coordinated crosstalk between decidual stromal cells, uterine
NK cells, and CD14+/CD68+ macrophages (59–62). Under opti-
mal circumstances, the transient invasion of uterine NK cells
and CD14+/CD68+ macrophages into the spiral arteries pave the
way for the second stage of remodeling that involves invasion of
trophoblasts into the vessels (52, 59).
M1 OR M2 IN NORMAL PREGNANCY, IT IS IN THE TIMING
It has been recently proposed that pregnancy is actually an
active and highly regulated immunologic process (63). Success-
ful implantation requires a transient inflammatory phase that is
initiated by cytokines and prostaglandins within seminal fluid
(64). During the peri-implantation period, the polarization pat-
tern of decidual macrophages is skewed toward M1 (65). However,
as trophoblasts establish attachment into the endometrial lining
and invade the uterine stroma, decidual macrophages begin to
transition to a mixed M1/M2 profile (65). This mixed popula-
tion may represent M1/M2 or possibly a blend of M2 subtypes
(pro-inflammatory M2b mixed with anti-inflammatory M2a and
M2c). This mixed polarization pattern continues through the first
trimester and the early phase of the second trimester of pregnancy
when the uterine vasculature is undergoing extensive remodeling
in order to establish an adequate placental–fetal blood supply (63).
After placental development is complete, the decidua shifts toward
a pro-M2 environment, which prevents rejection of the fetus and
allows fetal growth until parturition. Parturition, which is another
inflammatory event, is preceded by an influx of macrophages into
the myometrium and decidua (3–5). This inflammatory process
promotes the contraction of the uterus, expulsion of the baby,
ejection of the placenta, and uterine involution (57).
A2V, which is an isoform of the alpha subunit of vacuolar
ATPase (V-ATPase), is a key immune regulator important for
implantation (66). At least in normal murine pregnancy, A2V is
expressed in sperm, embryo, and endometrium (65), and loss of
a2v results in reproductive failure (67). In the reproductive tract,
a2V promotes a transient pro-inflammatory effect followed by a
balanced immune response that facilitates embryo implantation
without rejection. During the pre-implantation period, cleavage
of a2V in semen fluid releases a soluble N-terminus portion of the
protein (a2NTD). Seminal a2NTD has pro-inflammatory effects
such as upregulation of leukemia inhibitory factor (LIF), IL-1β,
TNF-α, and MCP-1 gene expression in the uterus, creating a tran-
sient pro-M1 effect. The developing embryo continues to produce
a2V, which continues to stimulate uterine MCP-1. This in turn
attracts new macrophages into the endometrium leading to a
more balanced M1/M2 ratio and protection against rejection of the
fetus. In the BALB/c mouse, these studies clearly demonstrate that
a2V mediated induction of MCP-1 is important for proper regula-
tion of M1/M2 during early pregnancy (65, 67). Additional factors
present within the decidualized tissue that influence macrophage
polarization of invading macrophages also contribute to tolerance.
As pregnancy progresses, the M1/M2 ratio decreases (23, 27)
and the population of decidual macrophages become more het-
erogeneous. This, in part, is caused by the uneven spatial dis-
tribution of neighboring leukocytes and trophoblasts within the
decidua, which provide different cues to resident macrophages.
Events that account for these changes include the contribu-
tion of immunoregulatory molecules from trophoblasts such
as HLA-G (68, 69), TGF-β (40), and VIP (41). These com-
pounds have direct effects on macrophages or on Tregs, which
express pro-M2 factors such as IDO and IL-10 (1). In con-
trast, CD56bright/CD16low NK cells, which are intimately asso-
ciated with decidual macrophages invading the spiral arteries,
produce pro-M1 IFN-γ (70) and TNF-α (11). Houser et al. identi-
fied two distinct macrophage subsets in first trimester decidua
based on the degree of CD11c expression (24). Regardless of
the degree of Cd11c expression, these cells uniformly expressed
CD68 and CD14. CD11cHI macrophages expressed less phago-
cytic receptors such as CD209 (DC-SIGN) and CD206 (man-
nose receptor) compared to CD11cLO macrophages. CD11cHI and
CD11cLO macrophages also had different transcriptional profiles.
For example, CD11cHI macrophages express genes involved in
invasion, mobility, inflammatory processes including lipid metab-
olism, and anti-apoptotic effects, whereas CD11cLO macrophages
express genes that regulate growth and development, as well
extracellular communication including networking. CD11cLO
macrophages may be the subpopulation of cells that actively sup-
press CD56bright/CD16low NK cell mediated killing of invading
trophoblasts (2). On the other hand, the transcriptional profile of
CD11cHI macrophages suggests that these cells participate in the
remodeling of the uterine arteries that occurs during this stage of
pregnancy.
During the growth phase of pregnancy, the predominant
immunological feature is the induction of an anti-inflammatory
state. It is presumed that the immunosuppressive qualities
observed in decidual macrophages studied from first trimester
pregnancies continue to be present as pregnancy advances (71).
This notion is supported by a several studies that evaluated
macrophages isolated from term decidua. First, the methylation
pattern of these cells show silencing of genes that encode M1
markers such as TLR9, IL1B, IL12RB2, CD48, and FGR, whereas
genes associated with M2 polarity such as CCL13, CCL14, A2M,
HNMT, and IL10 were hypomethylated (25). Second, decidual
macrophages express M2 polarity characteristics such as reduced
expression of co-stimulatory molecule CD86 with spontaneous
production of high levels of IL-10 and IDO (72). Third, decid-
ual macrophages express C-type lectin receptors such as CD206
throughout pregnancy (73), which is more in line with an M2
phenotype (71).
Normal parturition is an inflammatory process characterized
by an enhanced expression of IL-1β, IL-6, and IL-8 with an accu-
mulation of leukocytes in the cervix, fetal membranes, decidua,
and myometrium (74). Macrophages are one of the predominant
cell types in the decidua and myometrium during normal parturi-
tion. CD68+ macrophages begin to invade the decidua a few days
before parturition (3, 4), which coincides with a global increase
in the production of chemokines such as CCL2 (MCP-1), CCL4
(MIP-1β), CCL5 (Rantes), CXCL8 (IL-8), and CXCL10 (IP-10)
within the decidua (75). Immediately before parturition, a wave of
macrophages invades the myometrium (4), resulting in an increase
in pro and anti-inflammatory cytokines such as IL-1β, IL-6, IL-12,
and IL-10. To date, the polarity profile of macrophages invading
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the maternal–fetal interface before or during labor has not been
determined.
Although the density of Hofbauer cells within the villous mes-
enchyme fluctuates with gestational age (36), the limited charac-
terization of these cells suggests that they display a commitment
to M2 related functions. DNA methylation profiling of Hofbauer
cells obtained from term placentas show that pro-M1 genes such as
TLR9, IL1B, IL12RB2, CD48, and FGR are silenced (25). In con-
trast, pro-M2 genes such as CCL2, CCL13, CCL14, CD209, and
A2M are hypomethylated, and thus, available for expression (25).
Hofbauer cells constitutively express anti-inflammatory cytokines
such as IL-10 and TGF-β1 (38), which may in part be related
to the immune suppressive effects of neighboring mesenchymal
stem cells that have the capacity to shift macrophages from an
M1 phenotype to M2 (76). It is also likely that arginase I and
II activity from surrounding villous trophoblasts (22) reduces
extracellular arginine pools within the villous mesenchyme that
would be required for translation of iNOS and differentiation
into M1.
M1/M2 IMBALANCES DURING EARLY PREGNANCY
It is noteworthy that some obstetric complications associated with
decidual M1/M2 imbalances occur during the early inflamma-
tory phase of pregnancy. Under these circumstances, it is likely
that the surrounding environment supports M1 polarization over
M2. Some examples include spontaneous abortions and disorders
involving inadequate remodeling of the uterine arteries.
Spontaneous abortions that occur within 12 weeks gestation are
associated with an increased influx of macrophages in the decid-
ual stroma (12, 77). In one study, decidual macrophages from
spontaneous abortions had increased Fas-L expression, which
coincided with an increased rate of trophoblast apoptosis (12).
It was proposed that the increased FasL-expressing population of
macrophages reflected M1 activation (12); however, this is yet to be
proven. Jaiswal et al. recently demonstrated that a shift toward M1
polarization at the maternal–fetal interface enhances abortion in
CBA×DBA/2 mouse matings treated with LPS (67). The under-
lying mechanism involved a significant decrease in placental a2V
coupled with a decrease in uterine MCP-1 expression.
Inadequate remodeling of the uterine spiral arteries is asso-
ciated with a spectrum of obstetric complications such as pre-
eclampsia, intrauterine growth restriction, pre-term birth, pre-
term premature rupture of membranes (PPROM), late sporadic
miscarriage, and premature separation of the placenta from the
uterus (78). During optimal spiral artery remodeling, there is a
transient influx of NK cells and activated CD68+ macrophages
into the vessel wall. This leukocytic influx, which is described
as stage 1 remodeling, is thought to initiate the disruption of
the organized smooth muscle layer and endothelium needed
for subsequent trophoblast invasion into the vessel (59). Pro-
M2 stromal macrophages in the outer periphery of the vessel
assist in controlling inflammation by phagocytizing potentially
pro-inflammatory cellular debris and secreting anti-inflammatory
TGF-β1 (40). Excessive M1 or M2b activity during the early phase
of remodeling can prevent the resolution of this inflammatory
phase, thus, disrupting trophoblast invasion into the arterial wall
and preventing complete remodeling of the vessel (52, 59). Indeed,
reduced trophoblast invasion into utero-placental spiral arter-
ies is associated with an excess of activated macrophages in and
around these arteries (79, 80). Macrophages activated by exoge-
nous TNF-α, tryptophan depletion (which reduces production
of IDO), GM-CSF, or M-CSF promote apoptosis of extravillous
trophoblasts in vitro (80, 81).
M1/M2 IMBALANCES DURING LATE PREGNANCY
Decidual inflammation is also presumed to produce M1 or M2b
excess in the pathogenesis of uterine atherosis. Uterine atherosis
is a late pregnancy lesion of the decidua that is characterized by
the accumulation of lipid filled CD68+ foamy macrophages in
the subendothelial layer of uterine spiral arteries (14, 82). This
lesion is also associated with increased local TNF-α (83). In rare
instances, acute atherosis has also been observed in the myometrial
segments of the spiral arteries (78, 82). During early pregnancy,
acute atherosis can also be seen in cases of defective spiral artery
remodeling (78). In this instance, the lesions are present in the
lower section of the arteries where they feed into the intervillous
space (82).
Staff and Redman proposed that acute atherosis is an end result
of various inflammatory pathways triggered by immunologic,
genetic, and/or hemodynamic influences (sequela to impaired spi-
ral arterial remodeling and perturbed laminar blood flow) that
may be working singly or in combination (82). This hypothe-
sis is based on the observation that acute atherosis is found in
a wide range of pregnancy complications such as pre-eclampsia,
fetal growth restriction, and certain autoimmune diseases (sys-
temic lupus erythematosus and antiphospholipid syndrome). It
has also been suggested that infectious organisms implicated in
promoting cardiovascular disease such as Chlamydia pneumo-
niae may play a role in initiating or activating uterine atherosis
(84). Recent work in our laboratory suggests that the periodon-
tal pathogen, Porphyromonas gingivalis, which is implicated in
promoting cardiovascular disease (85), may indeed have such an
effect.
M1/M2 IMBALANCES ASSOCIATED WITH INTRAUTERINE
INFECTION
Porphyromonas gingivalis is a common periodontal pathogen of
human beings that is also implicated in low-birth weight, fetal
growth restriction,pre-eclampsia,and spontaneous pre-term birth
(86–93). In prototypical M2 Balb/c mice, intrauterine infection
with P. gingivalis induces pro-M1 or M2b inflammatory responses
such as increased TNF-α and IFN-γ with suppression of IL-
10, and fetal growth restriction (94, 95). Using a rat model of
intrauterine infection, we observed that the local presence of P.
gingivalis within the uterus produced lesions suggestive of an
M1>M2 or M2b>M2a, M2c imbalance. Namely, infected dams
exhibited acute arteritis within the endometrium and metrial tri-
angle characterized by perivascular necrosis, hyaline degeneration
with varying degrees of thrombosis (96, 97). Moreover, the spi-
ral arteries had increased densities of CD68+ macrophages, with
increased stromal TNF-α and a concomitant decrease in extrav-
illous trophoblast invasion into the placental bed. Since this was
an acute study (4 days duration), we did not observe lipid filled
macrophages surrounding affected spiral arteries. Nevertheless,
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these results provide a compelling argument that certain bacterial
infections may promote M1/M2 imbalances that in the placental
bed have a negative impact on spiral artery remodeling.
To date, there is no evidence that pro-M1 activity is actually
involved in the pathogenesis of chorioamnionitis and pre-term
delivery. Rather, acute chorioamnionitis may actually promote M2
polarization. Decidual macrophages in gestation day 16 FVB/NJ
mice sustain an M2 polarity phenotype even after LPS treat-
ment (98). C57BL/6 mice, which are resistant to chorioamnionitis
during intrauterine infection with Ureaplasma parvum (99), do
not develop pro-M1 responses, instead C57BL/6 mice exhibit a
pro-M2 profile within the placenta and decidua (100). This is
particularly intriguing since C57BL/6 mice are known for their
prototypical M1 immune responses (8). Human chorioamni-
otic and umbilical cord macrophages express more nuclear IL-33
(also known as full length IL-33) during acute chorioamnioni-
tis (101). Nuclear IL-33 acts as a transcriptional regulator that
has been shown to suppress production of LPS-stimulated pro-
inflammatory cytokines in vitro (102). Moreover, extracellular or
mature IL-33 released from activated or dying cells promotes
M2 polarization of macrophages at the site of inflammation
(103). At best, pro-M2 activation during chorioamnionitis may
minimize detrimental inflammation associated with chorioam-
nionitis, or it may enhance infection by suppressing antimicrobial
responses.
Manipulation of macrophage polarity at the maternal–fetal
interface by infectious agents can impact pregnancy outcomes. The
obligate intracellular parasite Toxoplasma gondii can invade the
placenta and fetus, resulting in spontaneous abortion, stillbirth,
fetal neurological, and ocular damage (104). A virulent strain of
T. gondii, TgCtwh3, actively induces M2 polarization in infected
macrophages (15). TgCtwh3 rapidly invades the placenta produc-
ing a heavy parasite burden with minimal inflammation but a
high rate of trophoblast apoptosis (15). On the other hand, less
virulent strain TgCtwh6 triggers pro-M1 responses in infected
macrophages (15). TgCtwh6 can still invade the placenta, but
infection is contained and associated with a profound lympho-
cytic inflammatory response with trophoblast apoptosis that is
less extensive than TgCtwh3 (15).
HOFBAUER CELLS IN COMPLICATED PREGNANCY
Placental Hofbauer cells are responsive to paracrine signals from
surrounding cells within the chorionic villus (105). Alterations in
Hofbauer cell densities within the villi have been reported during
chorioamnionitis (106, 107), but there is no evidence that these
cells shift to M1 polarity phenotype during chorioamnionitis.
Instead, HIV infected Hofbauer cells or cells from chorioamnioni-
tis cases continue to display M2 characteristics such as production
of IL-10, TGF-β, expression of DC-SIGN, CD163, and mannose
receptor/CD206 (38, 39). In another study, Hofbauer cells from
chorioamnionitis patients and healthy controls had similar gene
expression profiles, which were not considered to be committed to
either M1 or M2 (108).
Interestingly, it was reported that hyperglycemia can shift Hof-
bauer cells toward M1 activation (109). Hofbauer cells isolated
from diabetic women displayed characteristics that could be attrib-
uted to either M1or M2b phenotype (decreased CD163, CD209,
IL-10 with increased CD68, CCR7, and IL-1β) (109). Further,
when rat Hofbauer cells were cultured in high-glucose conditions
in vitro, these cells expressed increased levels of NOS2 gene expres-
sion and NO, clear markers of M1 activation (109). But a caveat
of that experiment was that Hofbauer cells were cultured in
RPMI media, which contains supraphysiologic levels of arginine
(7). High-arginine concentrations in RPMI are not representative
of the tissue microenvironment, especially during inflammation
(7). Further, high-arginine levels will promote iNOS activation in
macrophages in vitro (7).
Folate receptor β (FR-β) is preferentially expressed on M2
polarized macrophages, and is considered a biomarker for
immunoregulatory M2 macrophages (110). Decreased expres-
sion of FR-β and CD163, but not CD68, has been observed in
Hofbauer cells isolated from women with severe pre-term pre-
eclampsia (111) suggesting that in this syndrome, Hofbauer cells
may have shifted toward M1 polarity. This would be consis-
tent with Aziza et al.’s study (112) that reported increased iNOS
with concurrent decreased eNOS in placentas from women with
pre-eclampsia.
Villitis of unknown etiology (VUE) is an inflammatory lesion
of the chorionic villi that is associated with intrauterine fetal
growth restriction and perinatal morbidity and mortality (105).
VUE is characterized by influxes of Hofbauer cells, maternal
T-cells (more CD8+ than CD4+), and increased expression of
chemokines (CXCL9, CXCL10, CXCL11, CXCL13, CCL4, CCL5,
CXCR3, CCR5) within the placental villi (113, 114). It has been
suggested that the increased expression of chemokines and their
receptors within the villous mesenchyme of VUE patients pro-
vides the pro-migratory signals that promote increased migration
of Hofbauer cells and maternal T-cells into the villous (115).
Hofbauer cells do migrate in response to fibroblast secreted
MCP-1 in vitro (106). Whether or not changes in villous mes-
enchyme promote M1 polarization of Hofbauer cells remains to
be determined.
CONCLUSION
Macrophages serve important roles in the development of hemo-
chorial placentation, maintenance of pregnancy, and initiation of
parturition. As cells that are highly responsive to altering their
polarization pattern in vivo, the mixed M polarity phenotypes
present in the decidua reflect the heterogeneous nature of the
maternal–fetal interface. Both spatial and temporal regulation of
M1 and M2 polarization is required for successful pregnancy.
Similarly, ill-timed or ill-placed macrophage polarization at the
maternal–fetal interface is associated with pregnancy complica-
tions and poor outcomes. Despite recent insights into M1/M2
dynamics at the maternal–fetal interface, there are still critical
knowledge gaps concerning the in situ context of macrophage
polarity, the mechanisms that promote dysregulation, and its
impact on healthy pregnancy and obstetric disease.
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